Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin
© 2020 Elsevier B.V. Programmed death ligand 1 (PD-L1) is overexpressed in some metastatic breast cancer subtypes, specifically triple-negative breast cancer (TNBC). This feature can assist in the eradication of anti-tumor immunity, thereby enhancing the survival of the tumor. This study aims to exp...
Saved in:
Main Authors: | Prachya Kongtawelert, Benjawan Wudtiwai, Thuzar Hla Shwe, Peraphan Pothacharoen, Thanyaluck Phitak |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087655505&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70646 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
by: Prachya Kongtawelert, et al.
Published: (2020) -
Inhibitory effects of sesamin on human osteoclastogenesis
by: Orawan Wanachewin, et al.
Published: (2018) -
Inhibitory effects of sesamin on human osteoclastogenesis
by: Orawan Wanachewin, et al.
Published: (2018) -
Chondroprotective and anti-inflammatory effects of sesamin
by: Thanyaluck Phitak, et al.
Published: (2018) -
Sesamin Promotes Neurite Outgrowth under Insufficient Nerve Growth Factor Condition in PC12 Cells through ERK1/2 Pathway and SIRT1 Modulation
by: Sasimol Udomruk, et al.
Published: (2020)